SciBase announces changes in senior management
CEO Pia Renaudin steps down, board initiates recruitment for successor, strategy unchanged.
See the latest news and media coverage for SciBase. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of AI-based solutions for skin disorders
scibase.comLast updated
In short: SciBase CEO Pia Renaudin stepped down as the company achieved FDA submissions and record sales growth for its Nevisense AI technology.
CEO Pia Renaudin steps down, board initiates recruitment for successor, strategy unchanged.
The submission seeks to clear Nevisense for keratinocyte skin cancer, the most common cancer in the US, with over 5.4 million annual cases.
Study published in Allergy found higher neonatal EIS scores linked to atopic dermatitis development in first year.
The reverse share split will reduce shares from 1,022,530,000 to 10,225,300.
Scibase, which develops AI-based systems for detection and prevention in dermatology, announces that Pia Renaudin has decided to leave her role as CEO...
SciBase Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced the submission of...
SciBase Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced the submission of a 510(k) premarket...
SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that ...
Track SciBase and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.